The Impact of SPC on Advanced Breast Cancer Patients
- Conditions
- Cancer, BreastBreast CancerQuality of LifePalliative Care
- Interventions
- Procedure: Specialist Palliative Care
- Registration Number
- NCT03612934
- Lead Sponsor
- Silesian University of Medicine
- Brief Summary
The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 144
the patient's conscious consent for examination and the ability to fill in the form by the patient herself.
- patients with cognitive disturbances disabling credible answers in the questionnaire, deceased patients or those discharged from the ward before 14 days of hospitalisation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients at the age of 65 years and over Specialist Palliative Care patients at the age of 65 years and over patients under the age of 65 years Specialist Palliative Care patients under the age of 65 years
- Primary Outcome Measures
Name Time Method Variation of performance status of patients before and after SPC 14 days performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)
Variation of intensification of patients negative symptoms before and after SPC 14 days intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)
Variation of quality of life of patients before and after SPC 14 days quality of life of patients of patients was assessed by quality of life uniscale (QoLU)
- Secondary Outcome Measures
Name Time Method